tiprankstipranks
Trending News
More News >
Love Pharma Inc (TSE:JOLT)
:JOLT
Canadian Market

Love Pharma Inc (JOLT) Income Statement

Compare
12 Followers

Love Pharma Inc Income Statement

Last quarter (Q3 2024), Love Pharma Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Love Pharma Inc's net income was $-69.31K. See Love Pharma Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Sep 20Sep 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ 36.90K$ ―$ ―
EBITDA
$ -748.52K$ -3.56M$ -9.47M$ -128.30K$ -329.88K
Operating Income
$ -415.74K$ -1.66M$ -8.24M$ -128.30K$ -329.88K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -765.74K$ -3.58M$ -9.52M$ -128.30K$ -329.88K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Love Pharma Inc Earnings and Revenue History